Product Information
TRIAMTERENE 50 MG CAPSULE is a generic product labeled by TruPharma LLC, priced at $5.9753 per EA under NDC 52817036410. Its NADAC has been published 181 times since Sep 22, 2021.
FDA first approved this application on Aug 19, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
TruPharma LLCNDC
52817036410
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
TRIAMTERENEApproval Type
Generic (ANDA)
FDA Application
ANDA211581FDA Approved
8/19/2019
TE Code
AB
On Market Since
12/12/2018
Pharmacological Classes
Price Statistics
The NADAC for TRIAMTERENE 50 MG CAPSULE has been published 181 times since Sep 22, 2021, and over the history we have for it it has declined 31.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.9753 per EA |
|---|---|
| All-time high | $8.7204 (Sep 14, 2022) |
| All-time low | $5.9753 (Sep 23, 2026) |
| 52-week high | $7.4785 |
| 52-week low | $5.9753 |
| Median price | $6.9288 |
| Average price | $7.2658 |
| Largest weekly change | -20.8% (Apr 17, 2024) |
| Weeks tracked | 181 |
| Tracking since | Sep 22, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Triamterene Capsules market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
TruPharma LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Triamterene Capsules market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Potassium-sparing Diuretic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TRIAMTERENE 50 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TRIAMTERENE 50 MG CAPSULE, manufactured by TruPharma LLC, is $5.9753 per EA (NDC 52817036410), effective Sep 30, 2026.
How has the price of TRIAMTERENE 50 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TRIAMTERENE 50 MG CAPSULE has declined 31.5%. It has been tracked across 181 weekly CMS publications since Sep 22, 2021.
What are the highest and lowest recorded NADAC prices for TRIAMTERENE 50 MG CAPSULE?
Since Sep 22, 2021, the NADAC for TRIAMTERENE 50 MG CAPSULE has ranged from a low of $5.9753 (Sep 23, 2026) to a high of $8.7204 (Sep 14, 2022), with a median of $6.9288 per EA.
Are there cheaper alternatives to TRIAMTERENE 50 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of TRIAMTERENE 50 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TRIAMTERENE 50 MG CAPSULE?
TRIAMTERENE 50 MG CAPSULE (NDC 52817036410) is labeled by TruPharma LLC, and CMS classifies it as a generic product.